Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
Daniel Woronow, Christine Chamberlain, Ali Niak, Mark Avigan, Monika Houstoun, Cindy Kortepeter
Abstract
This case series identifies cases reported in the US Food and Drug Administration Adverse Event Reporting System of acute cholecystitis associated with use of glucagon-like peptide-1 receptor agonists that did not have gallbladder disease warnings in their labeling.
Topics & Concepts
MedicineFood and drug administrationAdverse Event Reporting SystemDrugAdverse effectAcute cholecystitisCholecystitisInternal medicineGallbladderGlucagonPharmacologyInsulinDiabetes Treatment and ManagementPharmaceutical studies and practicesNeuroendocrine Tumor Research Advances